Your current position:
Homepage
/
/
BGTA and Cambridge Innovation Institute visited Guangmin Investment

BGTA and Cambridge Innovation Institute visited Guangmin Investment

  • Categories:News Center
  • Author:
  • Origin:
  • Time of issue:2018-11-23 00:00
  • Views:

(Summary description)On November 23, 2018, BGTA and the Cambridge Institute of Innovation visited Guangmin Investment and held discussions on Sino-UK and China-EU cooperation in the field of biomedicine.

BGTA and Cambridge Innovation Institute visited Guangmin Investment

(Summary description)On November 23, 2018, BGTA and the Cambridge Institute of Innovation visited Guangmin Investment and held discussions on Sino-UK and China-EU cooperation in the field of biomedicine.

  • Categories:News Center
  • Author:
  • Origin:
  • Time of issue:2018-11-23 00:00
  • Views:
Information

On November 23, 2018, BGTA and the Cambridge Institute of Innovation visited Guangmin Investment and held discussions on Sino-UK and China-EU cooperation in the field of biomedicine.

 

BGTA

 

BGTA is a high-tech innovation incubation and acceleration platform headquartered in London, UK. It has branches in key cities in China to deeply explore multiple vertical industries such as financial technology, the Internet of Things, clean energy, big data and smart cities, and actively participate in the construction of the international ecosystem. It has carried out constructive partnerships with domestic and foreign industry leaders, scientific research institutions, investment institutions and governments, and has achieved rich results. BGTA will exert the all-round platform effect of co-construction, communication, cooperation, training, policies, regulations, investment and financing, and spare no effort to promote open innovation and promote global economic development.

 

Cambridge, UK

 

Cambridge, UK, as one of the important bases for research and development of biomedical technology in Europe, is the birthplace of many biotech companies and important technologies. A large number of biotechnology companies, scientific research institutions and technology consulting companies have jointly formed Cambridge's unique biotechnology innovation ecosystem, which has fostered many high-quality pharmaceutical enterprises, such as Astex Therapeutics, which focuses on cancer treatment; Solexa, which focuses on nanotechnology (acquired by Illumina after its technology); And the world's first approved anti-tumor necrosis factor TNF - α Pharmaceutical Humira and other companies. AstraZeneca, a leading pharmaceutical company in the world, is also located in Cambridge, one of its three strategic research and development centers in the world. As an important part of BGTA's innovation ecosystem, the Cambridge Innovation Academy, based in Cambridge, has accumulated many biomedical science and technology innovation enterprises and R&D team resources.

 

The Cambridge Innovation Institute is headquartered in Cambridge, UK, based on St. John's Innovation Center, and located in the core area of Cambridge University. The college focuses on education, training and scientific research and development in the fields of innovation and entrepreneurship as well as high-tech fields, and injects new impetus into enterprises' innovation cognition and innovation practice. The Cambridge Institute of Innovation has close and in-depth cooperation with Cambridge University's top research institutions in the field of innovation.

SERVICE HOTLINE

(020)8981 0500

HOME    |    ABOUT    |    INVESTMENT    |     NEWS    |    CONTACT

Copyright◎2024 INFINITE CAPITAL HOLDING COMPANY 

粤ICP备2023032959号-1     ​BY : xinne